Brief: Immunocore Reports Dosing Of First Patient With Immtav Bispecific Molecule For Chronic Hepatitis B

Immunocore Holdings

18/05/2021 21:51

May 18 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE ANNOUNCES DOSING OF FIRST PATIENT WITH IMMTAV®
BISPECIFIC MOLECULE FOR CHRONIC HEPATITIS B

Source text for Eikon:  ID:nGNX3Xx7Jm 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))